TY - JOUR
T1 - Monozygotic twins with DYT-TOR1A showing jerking movements and levodopa responsiveness
AU - Hanaoka, Yoshiyuki
AU - Akiyama, Tomoyuki
AU - Yoshinaga, Harumi
AU - Miyamoto, Ryousuke
AU - Kawarai, Toshitaka
AU - Kaji, Ryuji
AU - Kobayashi, Katsuhiro
N1 - Funding Information:
The authors thank the patients and their family for their participation in this study and permission to use the video. They thank Ms. Yoshimi Mihara for her technical support. This work was supported by the Ministry of Health, Labour and Welfare of Japan (Grants-in-Aid from the Research Committee of CNS Degenerative Diseases, and Research on Rare and Intractable Diseases), the Japan Agency for Medical Research and Development, AMED (Grants-in-Aid from the Research Committee on Practical Research Project for Rare/Intractable Diseases, and Grants-in-Aid for the core hospitals for Initiative on Rare and Undiagnosed Diseases) (Grant to T.K.). We thank Eibunkousei.net ( http://www.eibunkousei.net/ ) for English language editing.
Publisher Copyright:
© 2021 The Japanese Society of Child Neurology
PY - 2021/8
Y1 - 2021/8
N2 - Background: DYT-TOR1A is caused by a GAG deletion in the TOR1A gene. While it usually manifests as early-onset dystonia, its phenotype is extremely diverse, even within one family. Recent reports have revealed that some DYT-TOR1A cases have novel mutations in the TOR1A gene while others have mutations in both TOR1A and another DYT gene (THAP1 or SGCE). Our understanding of the correlation between genotype and phenotype is becoming increasingly complicated. Case presentations: Here, we report on monozygotic twins who developed dystonia in childhood. The two children had different presentations in terms of onset age and dominant disturbances, but both exhibited marked diurnal fluctuation and jerking movements of the limbs as well as levodopa/levodopa-carbidopa responsiveness. These features are commonly associated with DYT/PARK-GCH1 and DYT-SGCE, yet these twins had no mutations in the GCH1 or SGCE genes. Whole exome sequencing eventually revealed a single GAG deletion in the TOR1A gene. Conclusion: Monozygotic twins whose only mutation was a GAG deletion in TOR1A exhibited DYT/PARK-GCH1-asssociated features and jerking movements reminiscent of myoclonus. This finding may expand the spectrum of phenotypes associated with DYT-TOR1A, and suggests that levodopa has potential as a treatment for DYT-TOR1A with DYT/PARK-GCH1-associated features.
AB - Background: DYT-TOR1A is caused by a GAG deletion in the TOR1A gene. While it usually manifests as early-onset dystonia, its phenotype is extremely diverse, even within one family. Recent reports have revealed that some DYT-TOR1A cases have novel mutations in the TOR1A gene while others have mutations in both TOR1A and another DYT gene (THAP1 or SGCE). Our understanding of the correlation between genotype and phenotype is becoming increasingly complicated. Case presentations: Here, we report on monozygotic twins who developed dystonia in childhood. The two children had different presentations in terms of onset age and dominant disturbances, but both exhibited marked diurnal fluctuation and jerking movements of the limbs as well as levodopa/levodopa-carbidopa responsiveness. These features are commonly associated with DYT/PARK-GCH1 and DYT-SGCE, yet these twins had no mutations in the GCH1 or SGCE genes. Whole exome sequencing eventually revealed a single GAG deletion in the TOR1A gene. Conclusion: Monozygotic twins whose only mutation was a GAG deletion in TOR1A exhibited DYT/PARK-GCH1-asssociated features and jerking movements reminiscent of myoclonus. This finding may expand the spectrum of phenotypes associated with DYT-TOR1A, and suggests that levodopa has potential as a treatment for DYT-TOR1A with DYT/PARK-GCH1-associated features.
KW - DYT-TOR1A
KW - Jerking movements
KW - Levodopa responsiveness
KW - Monozygotic twins
UR - http://www.scopus.com/inward/record.url?scp=85103700097&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103700097&partnerID=8YFLogxK
U2 - 10.1016/j.braindev.2021.03.005
DO - 10.1016/j.braindev.2021.03.005
M3 - Article
C2 - 33832800
AN - SCOPUS:85103700097
SN - 0387-7604
VL - 43
SP - 783
EP - 788
JO - Brain and Development
JF - Brain and Development
IS - 7
ER -